Tscan therapeutics named a top place to work by the boston globe for three consecutive years

Waltham, mass., dec. 05, 2024 (globe newswire) --  tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biotechnology company focused on the development of t cell receptor (tcr)-engineered t cell (tcr-t) therapies for the treatment of patients with cancer, today announced it has been named one of the top places to work in massachusetts in the 17th annual, employee-based survey from the boston globe. the 2024 top places to work issue was published online at globe.com/topplaces and will appear in globe magazine on sunday, december 8, 2024.
TCRX Ratings Summary
TCRX Quant Ranking